With the increasing burden of gastrointestinal (GI) disease, which is currently the third most common cause of death in the UK and the most common cause of hospital admission, there is an urgent need to develop new treatment options for GI conditions. For example, inflammatory bowel disease (IBD) affects over half a million people in […]
PartnershipTraining Lead nurse appointment to drive research development in Imperial nursing community
Nurses interact with patients and their families every day, and make up a large part of the clinical workforce in the NHS. Their involvement in research is invaluable, as it gives patient-centred approach another dimension, given the different perspectives they have on clinical problems and how to address them. The NIHR Imperial BRC is investing […]
DiagnosticInnovationPartnershipPrevention New imaging techniques map brain development from pregnancy
A team of researchers from Imperial College London, King’s College London, and the University of Oxford are developing new techniques which allow the brains of foetuses and babies to be scanned. The Developing Human Connectome Project (dHCP) is a research project funded by a €15 million grant from the European Research Council, and is designed […]
InnovationPartnership Patient and public involvement to inform priorities for funding of infection research
The NIHR and the Health Research Authority (HRA) have set out clear aims and objectives for improving patient and public involvement (PPI) in research. PPI has been defined by the national NHS advisory group INVOLVE, as active partnership between members of the public and researchers in the activities, organisation and governance of research. However, PPI […]
Gestational trophoblastic neoplasia is a collective term for a number of malignant pregnancy-related disorders, such as choriocarcinoma and placental site trophoblastic tumours that invade locally or metastasise. This disease affects approximately 18,000 women globally every year, and is treated with chemotherapy, using human chorionic gonadotropin (hCG) in serum as a sole response biomarker. However even […]
Harnessing world-leading discovery science and clinical expertise to develop innovative therapeutics, devices and diagnostics for healthcare
Examples of research projects testing out new drugs, devices and diagnostics in humans for the first time. The BRC is specifically aimed at supporting these kinds of experimental medicine studies.
The NIHR Imperial BRC has developed a range of innovative device technologies, in collaboration with scientists in our Faculties of Natural Sciences and Engineering. Some of the most recent are highlighted here.
The NIHR Imperial BRC has a strong, successful track record of collaborating with life sciences and other related industries, academic institutions, charities and research organisations. Most recent examples can be found here.